Dermatan sulfate: new functions from an old glycosaminoglycan
Top Cited Papers
Open Access
- 1 September 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 12 (9) , 117R-125R
- https://doi.org/10.1093/glycob/cwf066
Abstract
Glycosaminoglycans constitute a considerable fraction of the glycoconjugates found on cellular membranes and in the extracellular matrix of virtually all mammalian tissues. Their ability to bind and alter protein–protein interactions or enzymatic activity has identified them as important determinants of cellular responsiveness in development, homeostasis, and disease. Although heparan sulfate tends to be emphasized as the most biologically active glycosaminoglycan, dermatan sulfate is a particularly attractive subject for further study because it is expressed in many mammalian tissues and it is the predominant glycan present in skin. Dermatan and dermatan sulfate proteoglycans have also been implicated in cardiovascular disease, tumorigenesis, infection, wound repair, and fibrosis. Growing evidence suggests that this glycosaminoglycan, like the better studied heparin and heparan sulfate, is an important cofactor in a variety of cell behaviors.Keywords
This publication has 88 references indexed in Scilit:
- WISP-1 Binds to Decorin and BiglycanJournal of Biological Chemistry, 2001
- Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4Journal of Clinical Investigation, 2001
- Altered Dermatan Sulfate Structure and Reduced Heparin Cofactor II-stimulating Activity of Biglycan and Decorin from Human Atherosclerotic PlaquePublished by Elsevier ,2000
- Heparan Sulfate Chains from Glypican and Syndecans Bind the Hep II Domain of Fibronectin Similarly Despite Minor Structural DifferencesPublished by Elsevier ,2000
- Decorin Links Low-Density Lipoproteins (LDL) to Collagen A Novel Mechanism for Retention of LDL in the Atherosclerotic PlaqueTrends in Cardiovascular Medicine, 1999
- Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.Journal of Clinical Investigation, 1997
- Syndecans-1 and -4 Are Induced During Wound Repair of Neonatal but Not Fetal SkinJournal of Investigative Dermatology, 1996
- Transforming growth factor‐β induces selective increase of proteoglycan production and changes in the copolymeric structure of dermatan sulphate in human skin fibroblastsEuropean Journal of Biochemistry, 1992
- Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia.The Journal of cell biology, 1989
- Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin.The Journal of cell biology, 1987